JP2009515553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515553A5 JP2009515553A5 JP2008541268A JP2008541268A JP2009515553A5 JP 2009515553 A5 JP2009515553 A5 JP 2009515553A5 JP 2008541268 A JP2008541268 A JP 2008541268A JP 2008541268 A JP2008541268 A JP 2008541268A JP 2009515553 A5 JP2009515553 A5 JP 2009515553A5
- Authority
- JP
- Japan
- Prior art keywords
- test kit
- cells
- solution
- vegfr
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 7
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 6
- 108091008605 VEGF receptors Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 claims 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000002934 lysing effect Effects 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000001235 sensitizing effect Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 1
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73585405P | 2005-11-14 | 2005-11-14 | |
| PCT/US2006/044117 WO2007059094A2 (en) | 2005-11-14 | 2006-11-14 | Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009515553A JP2009515553A (ja) | 2009-04-16 |
| JP2009515553A5 true JP2009515553A5 (https=) | 2009-12-10 |
Family
ID=37814675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541268A Pending JP2009515553A (ja) | 2005-11-14 | 2006-11-14 | 癌の予知および予後と、癌治療のモニタリング |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070178494A1 (https=) |
| EP (1) | EP1963849A2 (https=) |
| JP (1) | JP2009515553A (https=) |
| KR (1) | KR20080073745A (https=) |
| CN (1) | CN101454668A (https=) |
| AU (1) | AU2006315592A1 (https=) |
| BR (1) | BRPI0618597A2 (https=) |
| CA (1) | CA2629860A1 (https=) |
| MX (1) | MX2008006239A (https=) |
| RU (1) | RU2008123406A (https=) |
| WO (1) | WO2007059094A2 (https=) |
| ZA (1) | ZA200804509B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1158985B1 (en) | 1999-01-13 | 2011-12-28 | Bayer HealthCare LLC | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| SI1478358T1 (sl) | 2002-02-11 | 2013-09-30 | Bayer Healthcare Llc | Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| EP1636585B2 (en) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| EP1663978B1 (en) | 2003-07-23 | 2007-11-28 | Bayer Pharmaceuticals Corporation | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| ATE482693T1 (de) | 2005-03-07 | 2010-10-15 | Bayer Schering Pharma Ag | Pharmazeutische zusammensetzung mit einem omega- carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs |
| WO2007047955A2 (en) * | 2005-10-21 | 2007-04-26 | Bayer Healthcare Llc | Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| WO2007056012A2 (en) * | 2005-11-02 | 2007-05-18 | Bayer Healthcare Llc | Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| ES2372217T3 (es) * | 2006-09-12 | 2012-01-17 | Genentech, Inc. | Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer de pulmón utilizando el gen de pdgfra, kit o kdr como marcador genético. |
| AR062927A1 (es) * | 2006-10-11 | 2008-12-17 | Bayer Healthcare Ag | 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada |
| US20100311106A1 (en) * | 2008-01-25 | 2010-12-09 | Hartmann Lynn C | Quantitation of lobular involution for breast cancer risk prediction |
| GB0814722D0 (en) * | 2008-08-12 | 2008-09-17 | Ge Healthcare Ltd | Treatment monitoring |
| EP2156834A1 (en) * | 2008-08-08 | 2010-02-24 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic pharmaceutical compositions comprising Sorafenib for the treatment of neoangiogenic pathologies of the eye |
| JP5439494B2 (ja) * | 2008-10-21 | 2014-03-12 | バイエル ヘルスケア エルエルシー | 肝細胞癌と関連するシグネチャ遺伝子の同定 |
| WO2011042829A1 (en) * | 2009-10-07 | 2011-04-14 | Koninklijke Philips Electronics N.V. | Method of evaluating toxicity level of a patient undergoing a cancer treatment |
| CN102053150B (zh) * | 2009-10-30 | 2013-07-17 | 上海交通大学医学院附属瑞金医院 | 一种人成骨肉瘤干细胞相关抗原标记物及其应用 |
| WO2012010552A1 (en) * | 2010-07-19 | 2012-01-26 | F. Hoffmann-La Roche Ag | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| WO2012016948A1 (en) * | 2010-08-02 | 2012-02-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor |
| PL2653546T3 (pl) * | 2010-12-13 | 2019-06-28 | Samsung Life Public Welfare Foundation | Marker do ustalenia rokowania raka żołądka i sposób ustalenia rokowania raka żołądka |
| US20140018255A1 (en) * | 2011-01-11 | 2014-01-16 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods for predicting the outcome of a cancer in a patient by analysing gene expression |
| WO2013173384A1 (en) * | 2012-05-16 | 2013-11-21 | Dale Wong | Method and system for sorting biological samples |
| KR102241063B1 (ko) * | 2013-03-15 | 2021-04-16 | 얀센 파마슈티카 엔.브이. | 예측성 바이오마커에 대한 검정법 |
| KR102200344B1 (ko) * | 2013-04-25 | 2021-01-11 | 씨비에스바이오사이언스 주식회사 | 간세포 종양에 있어서 분자-표적 치료의 감수성을 증가시키기 위한 분석방법 |
| RU2546035C1 (ru) * | 2014-04-15 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития метастазов у больных меланомой кожи |
| RU2643761C1 (ru) * | 2017-08-10 | 2018-02-05 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ расчета прогноза раннего прогрессирования меланомы кожи |
| WO2019074920A1 (en) * | 2017-10-10 | 2019-04-18 | Oncocyte Corporation | METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCER |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6635421B1 (en) * | 1997-12-09 | 2003-10-21 | Children's Medical Center Corporation | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer |
| US20030232400A1 (en) * | 2002-12-20 | 2003-12-18 | Susan Radka | Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome |
| US20060234931A1 (en) * | 2003-07-17 | 2006-10-19 | Biggs William H Iii | Treatment of diseases with kinase inhibitors |
| BRPI0508970A (pt) * | 2004-03-19 | 2007-08-21 | Penn State Res Found | método combinatórios e composições para o tratamento de melanoma |
-
2006
- 2006-11-14 BR BRPI0618597-5A patent/BRPI0618597A2/pt not_active IP Right Cessation
- 2006-11-14 US US11/598,824 patent/US20070178494A1/en not_active Abandoned
- 2006-11-14 EP EP06837519A patent/EP1963849A2/en not_active Withdrawn
- 2006-11-14 JP JP2008541268A patent/JP2009515553A/ja active Pending
- 2006-11-14 RU RU2008123406/15A patent/RU2008123406A/ru not_active Application Discontinuation
- 2006-11-14 CA CA002629860A patent/CA2629860A1/en not_active Abandoned
- 2006-11-14 MX MX2008006239A patent/MX2008006239A/es not_active Application Discontinuation
- 2006-11-14 CN CNA2006800505936A patent/CN101454668A/zh active Pending
- 2006-11-14 WO PCT/US2006/044117 patent/WO2007059094A2/en not_active Ceased
- 2006-11-14 AU AU2006315592A patent/AU2006315592A1/en not_active Abandoned
- 2006-11-14 KR KR1020087014220A patent/KR20080073745A/ko not_active Withdrawn
-
2008
- 2008-05-23 ZA ZA200804509A patent/ZA200804509B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009515553A5 (https=) | ||
| Wang et al. | Detection of SARS-CoV-2 and its mutated variants via CRISPR-Cas13-based transcription amplification | |
| Le et al. | Dual recognition element lateral flow assay toward multiplex strain specific influenza virus detection | |
| Zhou et al. | Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway | |
| ES2540108T3 (es) | Marcadores en la orina para la detección del cáncer de vejiga | |
| JP5416110B2 (ja) | ｉｎｖｉｖｏ細胞死を検出するためにｍｉＲＮＡを使用する方法 | |
| US20110301046A1 (en) | Methods of Determining Efficacy of Glucocorticoid Treatment of Eosinophilic Esophagitis | |
| JP2007525661A5 (https=) | ||
| JP2011528903A5 (https=) | ||
| JP2012526554A5 (https=) | ||
| KR20080114689A (ko) | 증가된 ｂｃｌ-2에 의한 암의 발견 | |
| JP2010536372A5 (https=) | ||
| JP2019500582A5 (https=) | ||
| Panta et al. | Salivary RNA signatures in oral cancer detection | |
| FI2398902T3 (fi) | Menetelmiä ja koostumuksia syövän diagnoosia ja hoitoa varten | |
| ES2747381T3 (es) | Biomarcador de hipertensión pulmonar | |
| JP2010521655A5 (https=) | ||
| ATE414180T1 (de) | Verwendung der gene kir2.3 und drd2 als molekulare marker zur diagnose von schizophrenie | |
| US12195795B2 (en) | Synthetic strands for nucleic acid sequencing and related methods and systems | |
| Saber et al. | Lack of acute phase response in the livers of mice exposed to diesel exhaust particles or carbon black by inhalation | |
| JP2022515221A (ja) | クロマチンマッピングアッセイ用のｄｎａバーコード化ヌクレオソーム | |
| Pereira et al. | Enlarging the toolbox against antimicrobial resistance: aptamers and CRISPR-Cas | |
| JP2011519030A5 (https=) | ||
| Roth et al. | Rapid biosensing method for detecting protein–DNA interactions | |
| Khoshbin et al. | A CRISPR/Cas12a-powered liquid crystal aptasensor for point-of-care detection of prostate-specific antigen for early-stage cancer diagnosis |